Patents by Inventor Cristian Fernandez

Cristian Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA
    Publication number: 20240041874
    Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.
    Type: Application
    Filed: August 10, 2023
    Publication date: February 8, 2024
    Inventors: Carmen Kahatt, José María Fernandez, Salvador Fudio, Arturo Soto, Pilar Lardelli, Cristian Fernandez
  • METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY
    Publication number: 20240041873
    Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.
    Type: Application
    Filed: August 10, 2023
    Publication date: February 8, 2024
    Inventors: Carmen Kahatt, José María Fernandez, Salvador Fudio, Arturo Soto, Pilar Lardelli, Cristian Fernandez
  • METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA
    Publication number: 20230390286
    Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.
    Type: Application
    Filed: August 10, 2023
    Publication date: December 7, 2023
    Inventors: Carmen Kahatt, José María Fernandez, Salvador Fudio, Arturo Soto, Pilar Lardelli, Cristian Fernandez
  • METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN FORMULATIONS
    Publication number: 20230027502
    Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.
    Type: Application
    Filed: May 29, 2020
    Publication date: January 26, 2023
    Inventors: Pilar Calvo, Carmen Kahatt, José María Fernandez, Maria Tobio, Salvador Fudio, Arturo Soto, Pilar Lardelli, Cristian Fernandez, Maria Del Mar Zarzuelo Alba, María de la Concepción Polanco Noain, Sonia Manzanaro López, Honorio Velasco
  • Intravitreal Lysine Acetylsalicylate As Treatment For Diabetic Retinopathy
    Publication number: 20180177805
    Abstract: The invention relates to the use of a composition comprising lysine acetylsalicylate for the production of a drug in a form suitable for intravitreal administration, for the treatment of diabetic retinopathy.
    Type: Application
    Filed: May 26, 2016
    Publication date: June 28, 2018
    Applicants: Fundación Para El Fomento De La Investigación Sani taria Y Biomédica De La Comunitat Valencia FISABI, Universidad De Castilla La Mancha
    Inventors: José Juan Martínez Toldos, Cristian Fernandez Martínez, José María Ruiz Moreno